Is Global Regulatory Gridlock Slowing Modernization?

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2016
Volume 2016 eBook
Issue 3
Pages: s27–s32

PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology.

PDA’s first aging facilities survey suggests that post-approval changes play a major part in slowing pharmaceutical industry investment in new technology. Fewer pharmaceutical companies even do “technology scouting” today.

Maik Jornitz, who chaired the aging facilities taskforce during its first year, discusses challenges and what is required for change.

Download Pharmaceutical Technology’s

2016 Quality Throughout the Supply Chain eBook

.

 

 

Articles in this issue
PTeBook1116_QMS_185.jpg
Extending QMS to Contract Partners
PTeBook1116_Agalloco_sterilization_185.jpg
Too Much by Half: Misapplication of the Half-Cycle Approach to Sterilization
PTeBook1116_HumanPerformance_BPOG_185.jpg
Investigation Effectiveness Drives Human Performance Excellence
PTeBook1116_Aging_Facilities_185.jpg
Is Global Regulatory Gridlock Slowing Modernization?
PTeBook1116_Instant_GMP_185.jpg
Paperless Batch Records for the Masses
PTeBook1116_Pharma_Report_Card_185.jpg
Could Greater Transparency Improve Pharmaceutical Quality and Compliance?
PTeBook1116_Capsugel_185.jpg
Ensuring Quality in Pharmaceutical Raw Materials
PTeBook1116_MicrobialTesting_Challener_185.jpg
Microbiological Testing: Time is of the Essence
Recent Videos
Behind the Headlines episode 6
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sanofi Grows Antibody Production in France with €40 Million Investment

Feliza Mirasol
November 22nd 2024
Article

Sanofi will use this investment to increase its antibody bioproduction at its site in Lyon Gerland, France.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Three New European Facilities Established by BioPharmaSpec for R&D

Feliza Mirasol
November 21st 2024
Article

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing

Feliza Mirasol
November 19th 2024
Article

Financing from OrbiMed, Novo Holdings, Jeito Capital, and others will enable Alentis Therapeutics to advance its pipeline of Claudin-1-targeted ADCs for treating solid tumors.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

PTC Therapeutics Gains FDA Approval for AADC Deficiency Gene Therapy

Feliza Mirasol
November 19th 2024
Article

FDA's approval of eladocagene exuparvovec-tneq (Kebilidi) makes that product the first FDA-approved gene therapy for treating AADC deficiency.